Skip to main content

Maria Elena Ballarin Alins

Institutions of which they are part

Clinical Pharmacology
Vall Hebron Institut de Recerca

Maria Elena Ballarin Alins

Institutions of which they are part

Clinical Pharmacology
Vall Hebron Institut de Recerca

Projects

SGR CAT 2021

IP: Maria Antònia Agustí Escasany
Collaborators: Ángeles Mesas Idáñez, María Gloria Cereza García, Cristina Aguilera Martin, Maria Elena Ballarin Alins, Judit Riera Arnau, Immaculada Danes Carreras, Carla Sans Pola, Francisco Javier Medel Rebollo, Eulàlia Pérez Esquirol, Eduard Diogène Fadini, Mònica Sabaté Gallego, Montse Bosch Ferrer, Lourdes Vendrell Bosch, Lina Fernanda Camacho Arteaga, Lina Fernanda Camacho Arteaga
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00848
Duration: 01/01/2022 - 30/06/2025

El uso de antidepresivos y su asociación con ictus, frecuencia de hospitalizaciones y mortalidad, en la población anciana

IP: -
Collaborators: Maria Elena Ballarin Alins, Antonio San Jose Laporte, Olga Maisterra Santos, Mònica Sabaté Gallego, Lina Fernanda Camacho Arteaga, Lina Fernanda Camacho Arteaga
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI15/01429
Duration: 01/01/2016 - 30/11/2020

Fundació Institut Català de Farmacologia (GRC)

IP: -
Collaborators: María Gloria Cereza García, Maria Elena Ballarin Alins, Maria Antònia Agustí Escasany, Eulàlia Pérez Esquirol, Eduard Diogène Fadini, Mònica Sabaté Gallego, Lourdes Vendrell Bosch
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 21000
Reference: 2014 SGR 766
Duration: 01/01/2014 - 31/12/2016

Fundació Institut Català de Farmacologia

IP: -
Collaborators: María Gloria Cereza García, Maria Elena Ballarin Alins, Maria Antònia Agustí Escasany, Eulàlia Pérez Esquirol, Mònica Sabaté Gallego
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 42640
Reference: 2009 SGR 412
Duration: 01/01/2010 - 30/04/2014

Related news

The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.

The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine

The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.

Related professionals

Luisa Maria Martinez Sánchez

Luisa Maria Martinez Sánchez

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Francisco Javier  Ramos  Gómez

Francisco Javier Ramos Gómez

Shock, Organ Dysfunction and Resuscitation
Read more
Daniel Carranza Rojo

Daniel Carranza Rojo

Senior researcher
Pediatric Neurology
Read more
Maira Cortes Espriu

Maira Cortes Espriu

Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.